The Pharmaceutical Strategy Institute (PSI) is a Korean consulting firm helping local biotech companies reach success by providing strategic and legal counsel all along the value chain. Its founder & CEO, Dr Jung Yun-Taek, explains the different services his company provides, his role in shaping government policies to foster the biotech ecosystem, and discusses the potential of Korea to become the next Switzerland of pharmaceutical innovation.
I think that it is very likely that a Korean biotech company will license out a drug to a global company that will go on to achieve more than USD 1 billion in sales
